| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5569688 | The Journal for Nurse Practitioners | 2017 | 6 Pages |
Abstract
Basal insulin is a component of therapy for many patients with diabetes mellitus. Several concentrated basal insulins are newly available. Nurse practitioners should be aware and informed of the various concentration options as they manage their patients. This article reviews the available concentrated products with a focus on degludec insulin. Nurse practitioners should be knowledgeable of the resulting safety considerations, particularly during transitions of care, or conversions between products.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Jacqueline L. MS, PharmD, CDE, Kira B. PharmD, CDE,